AstroNova Made Good Faith Effort to Resolve Costly, Disruptive Proxy Contest in Collaborative and Amicable Manner

Stock Information for Redhill Biopharma Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Redhill Biopharma Ltd.

AstroNova Reports 8.5% Sequential Growth in Revenue for Third Quarter Fiscal 2026
AstroNova to Report Third Quarter Fiscal Year 2026 Financial Results on Wednesday, December 10
AstroNova Announces Amendment and Extension of Credit Agreement
AstroNova Reports Second-Quarter Fiscal 2026 Financial Results
AstroNova to Report Second Quarter Fiscal Year 2026 Financial Results on Tuesday, September 9
AstroNova Appoints Shawn Kravetz to Board of Directors
AstroNova Appoints Jorik E. Ittmann as President and Chief Executive Officer
Glass Lewis Endorses All Five Askeladden Nominees; Askeladden Comments on Resignation of CEO Greg Woods

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.